Creative One Wealth, LLC Intellia Therapeutics, Inc. Transaction History

Creative One Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $112,402 - $229,531	-1,929 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$100.76 - $138.36 $7,557 - $10,377	-75 Reduced 3.74%	1,929 $228,000
Q3 2021 Nov 16, 2021	SELL	$132.37 - $176.78 $65,655 - $87,682	-496 Reduced 19.84%	2,004 $269,000
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $116,475 - $209,200	2,500 New	2,500 $201,000

326

88.8M

673K

865K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.56B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Creative One Wealth, LLC with notifications on news.